We evaluated levels of various cytokines in plasma from M2T-CD33 treated mice and confirmed that M2T-CD33 did not induce significant changes in Th1, Th2, or Th17 cytokines, including those associated with cytokine release syndrome (CRS; Fig. 6A) [54]. Here, CD33 is linked to congenital rubella syndrome.